UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2014, Volume 312, Issue 10, pp. 1006 - 1015
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Blood Proteins - adverse effects | Myocardial Infarction - epidemiology | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Humans | Middle Aged | Kaplan-Meier Estimate | Myocardial Ischemia - prevention & control | Oximes - therapeutic use | Male | Secondary Prevention | Blood Proteins - therapeutic use | Incidence | Acute Coronary Syndrome - drug therapy | Benzaldehydes - adverse effects | Myocardial Infarction - drug therapy | Myocardial Ischemia - therapy | Cardiovascular Diseases - mortality | Female | Aged | Benzaldehydes - therapeutic use | Myocardial Ischemia - epidemiology | Complications and side effects | Development and progression | Care and treatment | Research | Acute coronary syndrome | Patient outcomes | Acute coronary syndromes | Cardiology | Medical treatment | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
2.
Full Text
Status Update and Interim Results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2)
European journal of vascular and endovascular surgery, ISSN 1078-5884, 2013, Volume 46, Issue 5, pp. 510 - 518
Surgery | Stroke | Carotid artery stenting | Carotid endarterectomy | Carotid artery stenosis | Randomized controlled trial | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - mortality | Humans | Middle Aged | Angioplasty - mortality | Male | Asymptomatic Diseases | Patient Selection | Endarterectomy, Carotid - adverse effects | Time Factors | Carotid Stenosis - diagnosis | Carotid Stenosis - mortality | Female | Stroke - mortality | Myocardial Infarction - etiology | Stents | Angioplasty - instrumentation | Carotid Stenosis - surgery | Severity of Illness Index | Risk Assessment | Risk Factors | Carotid Stenosis - therapy | Treatment Outcome | Endarterectomy, Carotid - mortality | Cardiovascular Agents - therapeutic use | Stroke - etiology | Angioplasty - adverse effects | Aged | Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2014, Volume 384, Issue 9958, pp. 1929 - 1935
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Biological and medical sciences | General aspects | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Acute Disease | Age Factors | Time-to-Treatment | Humans | Middle Aged | Male | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Stroke - drug therapy | Tissue Plasminogen Activator - adverse effects | Randomized Controlled Trials as Topic | Fibrinolytic Agents - adverse effects | Clinical Trials, Phase III as Topic | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - mortality | Aged, 80 and over | Female | Aged | Fibrinolytic Agents - administration & dosage | Infusions, Intravenous | Stroke - mortality | Stroke (Disease) | Complications and side effects | Dosage and administration | Drug therapy | Tissue plasminogen activator | Patient outcomes | Stroke | FDA approval | Mortality | Age | Clinical outcomes | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Annals of neurology, ISSN 0364-5134, 01/2014, Volume 75, Issue 1, pp. 67 - 76
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Diffusion Magnetic Resonance Imaging - standards | Stroke - metabolism | Prospective Studies | Humans | Stroke - diagnosis | Retrospective Studies | Diffusion Magnetic Resonance Imaging - methods | Ischemic Attack, Transient - metabolism | Ischemic Attack, Transient - diagnosis | Confidence intervals | Diffusion | Drunk driving | Index Medicus | Original
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2015, Volume 2015, Issue 3, pp. CD000024 - CD000024
Anticoagulants | Neurology | Brain Ischemia | Stroke | Treatment | ISCHAEMIC/UNSPECIFIED STROKE, TRANSIENT ISCHAEMIC ATTACK | Risk | Medical therapy | Heart & circulation | Medicine General & Introductory Medical Sciences | Ischemic stroke/TIA: treatment | Randomized Controlled Trials as Topic | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Stroke - prevention & control | Brain Ischemia - drug therapy | Humans | Anticoagulants - therapeutic use | Brain Ischemia - prevention & control | Stroke - drug therapy | Anticoagulants - adverse effects | Index Medicus
Journal Article
Lancet neurology, ISSN 1474-4422, 2013, Volume 12, Issue 6, pp. 539 - 545
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Brain Ischemia - epidemiology | Randomized Controlled Trials as Topic - methods | Brain Ischemia - drug therapy | Humans | Heparin - administration & dosage | Stroke - epidemiology | Stroke - drug therapy | Heparin, Low-Molecular-Weight - administration & dosage | Heparinoids - administration & dosage | Drug Delivery Systems - methods | Stroke (Disease) | Usage | Neurosciences | Glycosaminoglycans | Ischemia | Analysis | Patient outcomes | Anticoagulants (Medicine) | Stroke patients | Thromboembolism | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9834, pp. 2352 - 2363
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Biological and medical sciences | General aspects | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Recombinant Proteins - therapeutic use | Age Distribution | Humans | Middle Aged | Male | Secondary Prevention | Tissue Plasminogen Activator - therapeutic use | Recombinant Proteins - adverse effects | Tissue Plasminogen Activator - adverse effects | Young Adult | Fibrinolytic Agents - adverse effects | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy - methods | Aged, 80 and over | Adult | Female | Severity of Illness Index | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Stroke - drug therapy | Recombinant Proteins - administration & dosage | Brain Ischemia - drug therapy | Adolescent | Aged | Fibrinolytic Agents - administration & dosage | Infusions, Intravenous | Thrombolytic Therapy - adverse effects | Care and treatment | Venous thrombosis | Thrombolytic drugs | Ischemia | Patient outcomes | Medical research | Brain | Stroke | Blood pressure | Grants | Councils | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article